Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Blood Pressure Drug Recalled
03/21/2024
Jolynn Tumolo
Nearly 120,000 bottles of telmisartan tablets distributed in Tennessee, Rhode Island, and Puerto Rico are under recall for being out of specification for blend uniformity.
Nearly 120,000 bottles of telmisartan tablets distributed in Tennessee, Rhode Island, and Puerto Rico are under recall for being out of specification for blend uniformity.
Nearly 120,000 bottles of...
03/21/2024
Pharmacy Learning Network
News
Injections Recalled for Improper Storage
03/21/2024
Jolynn Tumolo
McKesson Medical-Surgical Inc. is recalling a trio of injections it distributed in New Mexico, Arizona, and Utah because the products were not stored according to drug label specifications.
McKesson Medical-Surgical Inc. is recalling a trio of injections it distributed in New Mexico, Arizona, and Utah because the products were not stored according to drug label specifications.
McKesson Medical-Surgical Inc....
03/21/2024
Pharmacy Learning Network

Advertisement

News
Substance Use Harm Reduction Approach Provides Support for Patients
03/20/2024
Lisa Kuhns, PhD
A harm reduction approach to substance use provides realistic support for patients who are hospitalized for other medical reasons, according to a Psychiatric News article.
A harm reduction approach to substance use provides realistic support for patients who are hospitalized for other medical reasons, according to a Psychiatric News article.
A harm reduction approach to...
03/20/2024
Pharmacy Learning Network
News
Patients Experience Weight Gain After Ozempic Discontinuation
03/18/2024

By Emry Lloyd

By Emry Lloyd
Patients are gaining back the weight they lost after discontinuing Ozempic. Experts do not recommend lifelong Ozempic use, and side effects highlighting discontinuation for patients struggling with weight loss.
Patients are gaining back the weight they lost after discontinuing Ozempic. Experts do not recommend lifelong Ozempic use, and side effects highlighting discontinuation for patients struggling with weight loss.
Patients are gaining back the...
03/18/2024
Pharmacy Learning Network
News
Xolair Approved for Patients With Food Allergies
03/18/2024
Jolynn Tumolo
The US Food and Drug Administration (FDA) recently approved Xolair (omalizumab) for the reduction of allergic reactions, including anaphylaxis, after accidental exposure to one or more foods in adults and children 1 year and older with...
The US Food and Drug Administration (FDA) recently approved Xolair (omalizumab) for the reduction of allergic reactions, including anaphylaxis, after accidental exposure to one or more foods in adults and children 1 year and older with...
The US Food and Drug...
03/18/2024
Pharmacy Learning Network

Advertisement

News
Adolescent Antidepressant Prescriptions Surge Amidst COVID-19 Fallout
03/14/2024
Lisa Kuhns, PhD
From 2016 to 2022, there has been an increase in dispensing antidepressants to adolescents and young adults. However, the rate of increase was 63.5% faster after the COVID-19 outbreak, according to a study published in Pediatrics.
From 2016 to 2022, there has been an increase in dispensing antidepressants to adolescents and young adults. However, the rate of increase was 63.5% faster after the COVID-19 outbreak, according to a study published in Pediatrics.
From 2016 to 2022, there has...
03/14/2024
Pharmacy Learning Network
News
Glucocorticoid Injection Recalled
03/13/2024
Jolynn Tumolo
Eugia US is recalling 10,080 vials of methylprednisolone acetate injectable suspension for failing to meet dissolution specifications.
Eugia US is recalling 10,080 vials of methylprednisolone acetate injectable suspension for failing to meet dissolution specifications.
Eugia US is recalling 10,080...
03/13/2024
Pharmacy Learning Network
News
Acne Medication Recalled
03/13/2024
Jolynn Tumolo
Defective containers have prompted Contract Pharmaceuticals Limited Canada to recall more than 57,000 bottles of clindamycin phosphate topical solution.
Defective containers have prompted Contract Pharmaceuticals Limited Canada to recall more than 57,000 bottles of clindamycin phosphate topical solution.
Defective containers have...
03/13/2024
Pharmacy Learning Network

Advertisement

News
Chemotherapy Tablets Recalled
03/13/2024
Jolynn Tumolo
Stason Pharmaceuticals Inc. is recalling 54,131 bottles of mercaptopurine tablets manufactured for Quinn Pharmaceuticals, Boca Raton, Florida.
Stason Pharmaceuticals Inc. is recalling 54,131 bottles of mercaptopurine tablets manufactured for Quinn Pharmaceuticals, Boca Raton, Florida.
Stason Pharmaceuticals Inc. is...
03/13/2024
Pharmacy Learning Network
News
Methadone Access Reform Needed to Address the US Opioid Crisis
03/08/2024

Emry Lloyd

Emry Lloyd
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis...
03/08/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use